Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Glaukos Corporation

GKOSNYSE
Healthcare
Medical - Devices
$105.78
$-1.95(-1.81%)
U.S. Market opens in 0h 44m

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1B
P/E Ratio-31.72
EPS (TTM)$-3.27
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$89.45
3 Months$58.37
1 Year Target$132.41

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $132.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.72 and a market capitalization of 6.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.85%
5-Day Change
-9.77%
1-Month Change
-6.65%
3-Month Change
-1.06%
6-Month Change
16.31%
Year-to-Date (YTD) Change
-4.50%
1-Year Change
9.38%
3-Year Change
127.007%
5-Year Change
24.11%
All-Time (Max) Change
238.69%

Contact Information

949 367 9600
229 Avenida Fabricante, Aliso Viejo, CA, 92672

Company Facts

9,950 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions